within Pharmacolibrary.Drugs.R_RespiratorySystem.R06A_AntihistaminesForSystemicUse.R06AX27_Desloratadine;

model Desloratadine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.6,
    Cl = 2.5555555555555553e-06,
    adminDuration = 600,
    adminMass = 5 / 1000000,
    adminCount = 1,
    Vd = 0.049,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.022166666666666668,
    Tlag = 10.020000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Desloratadine</td></tr><tr><td>ATC code:</td><td>R06AX27</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>49</td><td>L</td></tr>
    <tr><td>clearance:</td><td>9.2</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Desloratadine is a non-sedating second-generation antihistamine used to treat symptoms associated with allergic rhinitis and chronic idiopathic urticaria. It is the active metabolite of loratadine and is widely approved and used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported following single oral administration of 5 mg desloratadine in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Liu, T, et al., &amp; Liu, X (2024). Simultaneously Predicting Pharmacokinetics of Loratadine and Desloratadine in Children Using a Whole-Body Physiologically Based Pharmacokinetic Model. <i>Journal of clinical pharmacology</i> None –. DOI:<a href=\"https://doi.org/10.1002/jcph.6120\">10.1002/jcph.6120</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39171895/\">https://pubmed.ncbi.nlm.nih.gov/39171895</a></p></li><li><p>Affrime, M, et al., &amp; Cayen, M (2002). Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine. <i>Clinical pharmacokinetics</i> 41 Suppl 1 21–28. DOI:<a href=\"https://doi.org/10.2165/00003088-200241001-00004\">10.2165/00003088-200241001-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12169043/\">https://pubmed.ncbi.nlm.nih.gov/12169043</a></p></li><li><p>Simons, FE (2002). Comparative pharmacology of H1 antihistamines: clinical relevance. <i>The American journal of medicine</i> 113 Suppl 9A 38S–46S. DOI:<a href=\"https://doi.org/10.1016/s0002-9343(02)01436-5\">10.1016/s0002-9343(02)01436-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12517581/\">https://pubmed.ncbi.nlm.nih.gov/12517581</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.R.R06AX27 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Desloratadine;
